Denis Garceau, PhD
Chief Scientific Officer
Dr. Denis Garceau serves as Chief Scientific officer and has been with the Company since 1997. Dr Garceau directs BELLUS Health’s early drug development programs, from preclinical to clinical proof-of-concept of new products.
From 1986 to 1997, as a clinical scientist and product team leader for Hoechst Marion Roussel (now Sanofi), Dr. Garceau successfully oversaw North American clinical programs and participated in global clinical development steering committees. He was responsible for developing clinical operating plans, designing clinical protocols, and supervising clinical trials. In 1985-86, Dr. Garceau completed a post-doctorate Research fellowship in Pharmacology at Merck Canada. He is a board member of Centre d’excellence en recherche sur les maladies orphelines-Fondation Courtois (CERMO-FC) at UQAM.
Dr. Garceau holds a Ph.D. in Pharmacology from the Université de Montréal and is currently a guest lecturer for the faculty of pharmacy of the Université de Montréal and Université Laval.